View source for Talk:Assessment of the health impacts of H1N1 vaccination/Group B

[[Category:DARM exercise]]
== Pandemrix should not be used because of narcolepsy risk ==

 Oluyemi, Bate

{{discussion
|Statements= Pandemrix should not be used any more anywhere because its narcolepsy risk is too high. NOTE! The time of the statement is September 2010.
|Resolution= Not accepted because benefits are high and risks are small, uncertain and maybe caused by something else.
|Argumentation =

{{attack|B1 |All data compiled to date indicate that pandemic vaccines including Pandemrix match the excellent safety profile of seasonal influenza vaccines, which have been used for more than 60 years.The number of cases of side effects of H1N1 vaccines (including Pandemrix) is in line with normal background rates on a population basis.(European Medicines Agency.) |--[[User:Oluyemitoyinbo|Oluyemitoyinbo]] 11:12, 1 April 2011 (EEST)}} <ref name="ecdc_qa">[http://ecdc.europa.eu/en/healthtopics/H1N1/vaccines/Pages/QA_health_professionals_vaccines.aspx European Centre for Disease Prevention and Control (ECDC): Questions and answers]</ref>

{{attack|B2 |The European Medicines Agency says that no link between the Pandemrix swine flu vaccine and narcolepsy has been established|--[[User:Oluyemitoyinbo|Oluyemitoyinbo]] 12:17, 4 April 2011 (EEST)}} <ref>[http://yle.fi/uutiset/news/2010/09/eu_agency_no_link_between_pandemrix_and_narcolepsy_2006172.html YLE: EU agency does not find link between Pandemrix and narcolepsy]</ref>

{{attack|B3 |According to THL's (Finnish National Institute for Health and Welfare) Vaccine Department's head, Dr. Terhi Kilpi,`the Pandemrix vaccine alone did not cause narcolepsy in Finnish children`.|--[[User:Oluyemitoyinbo|Oluyemitoyinbo]] 09:51, 4 April 2011 (EEST)}} <ref name="rokotusinfo"/>

{{attack|B4 |Adjuvanted vaccines commonly provide a stronger immune response than unadjuvanted vaccines and also provide a broader immune response allowing for some potential drift of the influenza virus (Pandemrix is an adjuvanted vaccine).|--[[User:Oluyemitoyinbo|Oluyemitoyinbo]] 11:12, 1 April 2011 (EEST)}} <ref name="ecdc_qa"/>

{{attack|J1 |Despite risks, Pandemrix is an effective vaccine and has clearly net positive effects in countries where emergency treatment is poorly available for severe swine flu cases.|--[[User:Jouni|Jouni]] 23:05, 31 March 2011 (EEST)}}

{{attack|B5 |A positive effect of the vaccine can be felt from pregnant women, it gives immunization to the mother - to - be and the new born that is not eligible for vaccination until the age of six months. The adverse events reported so far have mainly been symptoms such as fever, nausea, headache, allergic reactions and injection site reactions, confirming the safety profile of the vaccine. The vaccine can even be given to breastfeeding mothers and this will reduce the chance that the infant will get influenza.|--[[User:Oluyemitoyinbo|Oluyemitoyinbo]] 11:20, 1 April 2011 (EEST)}} <ref name="ecdc_qa"/>

{{defend invalid|J2 |The reputation of Pandemrix is globally so poor that it is impossible to use it any more.|--[[User:Jouni|Jouni]] 23:05, 31 March 2011 (EEST)}}

:{{attack|B7 |Pandemrix vaccine was used in 38 countries worldwide during the 2009/2010 season. Increased cases of narcolepsy have been observed only in Finland, Iceland and Sweden (W.H.O). This I think makes its global reputation intact.|--[[User:Oluyemitoyinbo|Oluyemitoyinbo]] 12:27, 4 April 2011 (EEST)}} <ref>[http://www.euro.who.int/en/what-we-do/health-topics/disease-prevention/vaccines-and-immunization/news/news/2011/02/pandemrix-vaccine-and-increased-risk-of-narcolepsy WHO Europe]: Pandemrix® vaccine and increased risk of narcolepsy</ref>

:{{defend|B6 |A total of 2300 Reports of Adverse Reactions From Pandemrix Vaccine have been reported in Sweden|--[[User:Oluyemitoyinbo|Oluyemitoyinbo]] 12:10, 4 April 2011 (EEST)}} <ref>[http://preventdisease.com/news/09/113009_2300_reports_adverse_reactions_sweden.shtml PreventDisease.com]: Total of 2300 Reports of Adverse Reactions From Pandemrix Vaccine in Sweden</ref>

{{defend invalid|B8 |There maybe a conflict of interest in the approval of Pandemrix for swine flu vaccination in Finland|--[[User:Oluyemitoyinbo|Oluyemitoyinbo]] 12:50, 4 April 2011 (EEST)}}

:{{attack|B11 |According to Chancellor of Justice, Jaakko Jonkka, there's no direct [ evidence to support ] suspicion of bribery but there is a risky situation because the seller funds the buyer.|--[[User:Oluyemitoyinbo|Oluyemitoyinbo]] 12:57, 4 April 2011 (EEST) <ref name="rokotusinfo">[http://www.rokotusinfo.fi/english_html Rokotusinfo]</ref>}}

:{{defend|B9 |Vaccine Department's head at THL, Dr. Terhi Kilpi have a close relationship with GlaxoSmithKline, the manufactural of Pandemrix vaccine. |--[[User:Oluyemitoyinbo|Oluyemitoyinbo]] 12:50, 4 April 2011 (EEST)}} <ref name="rokotusinfo"/>

: {{defend|B10 |GlaxoSmithKline has funded several THL's activities with millions of euros.|--[[User:Oluyemitoyinbo|Oluyemitoyinbo]] 12:57, 4 April 2011 (EEST)}}

}}


{{comment|# |General comment: Add links to the pages from where you found the arguments.|--[[User:Jouni|Jouni]] 07:31, 2 April 2011 (EEST)}}

*[http://ecdc.europa.eu/en/healthtopics/H1N1/vaccines/Pages/QA_health_professionals_vaccines.aspx European Centre for Disease Prevention and Control (ECDC),2009 influenza A (H1N1) pandemic]
*[http://www.thl.fi/en_US/web/en/pressrelease?id=15437]
*[http://www.rokotusinfo.fi/english_html]

==See also==

==References==

<references/>